AmMa?ch,'iP9iorm'}  American  Pharmaceutical  Association.  149 
AMERICAN  PHARMACEUTICAL  ASSOCIATION. 
The  officers  of  the  Section  on  Scientific  Papers  would  again 
remind  you  that  the  annual  meeting  of  the  American  Pharmaceu- 
tical Association  to  be  held  in  Richmond,  Va.,  the  week  following- 
May  2,  19 10,  offers  the  last  and  in  many  respects  the  most  favorable 
opportunity  to  discuss  matters  of  scientific  interest  in  connection 
with  the  Pharmacopoeia  of  the  United  States  previous  to  the  meeting 
of  the  Pharmacopceial  Convention  to  be  held  in  Washington,  May 
10,  1910. 
To  insure  profitable  and  comprehensive  discussions,  it  will  be 
necessary  to  limit  the  number  of  communications  presented  at  each 
session,  and,  as  the  sessions  themselves  are  in  turn  limited,  the 
committee  would  request  that  all  members  of  the  association  who 
are  interested  in  the  work  of  the  Section  on  Scientific  Papers  will 
promptly  announce  their  willingness  to  contribute  to  the  programme 
and  indicate,  approximately,  the  time  that  they  will  require  to  present 
their  communications. 
Communications  to  be  printed  in  advance  of  the  meeting  should 
be  in  the  hands  of  the  printer  at  least  six  weeks  in  advance  of  the 
date  of  the  annual  meeting,  and  titles  with  the  accompanying 
abstracts  to  be  included  on  the  programme  should  be  in  the  hands  of 
the  Chairman  of  the  Section  at  least  one  month  in  advance  of  the 
meeting.  M.  I.  Wilbert, 
Chairman. 
The  meeting  of  the  City  of  Washington  Branch  of  the  American 
Pharmaceutical  Association,  February  2,  19 10,  was  devoted  to  a 
discussion  of  the  report  of  a  special  Committee  on  National  Formu- 
lary.   On  motion,  the  following  principles  were  endorsed : 
Object. — The  National  Formulary  should  be  a  book  of  remedies 
which  not  only  conserve  and  protect  the  welfare  of  the  people,  but 
also  represent  the  best  that  the  American  Pharmaceutical  Associa- 
tion stands  for. 
Nomenclature. — No  name  should  be  used  which  misleads  in  any 
particular. 
Standards. — It  is  believed  that  it  would  be  preferable  to  have  a 
definite  standard  prescribed,  when  practicable,  for  each  product 
recognized. 
Division  of  Book. — It  is  unwise  to  divide  the  book  into  two  parts. 
